Obesity and chronic kidney disease

Terapevticheskii Arkhiv

Volumn 83, Issue 6, 2011, Pages 66-70

  Bondar, I A ^a   Klimontov, V V ^a   Simakova, A I ^a  

^a NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Adipose tissue; Chronic kidney disease; Obesity

Indexed keywords

CHRONIC DISEASE; HUMAN; KIDNEY DISEASE; OBESITY; PATHOLOGY; REVIEW;

CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; OBESITY;

EID: 79960548732     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Hunley T. E., Ma L. J., Kon V. Scope and mechanisms of obesity-related renal diseasec Curr. Opin. Nephrol. Hypertens. 2010;19(3):227-234.
2. Gelber R. P., Kurth T., Kausz A. T. et al. Association between body mass index and CKD in apparently healthy men. Am. J. Kidney Dis. 2005;46(5):871-880. (Pubitemid 41505461)
3. Ishizaka Y., khizaka N., Tani M. et al. Association between changes in obesity parameters and incidence of chronic kidney disease in Japanese individuals. Kidney Blood Press. Res. 2009;32(2):141-149.
4. Ryu S., Chang Y., Woo H. Y. Changes in body weight predict CKD in healthy men. J. Am. Soc. Nephrol. 2008;19(9):1798-1805.
5. Foster M. C., Hwang S. J., Larson M. G. et al. Association between body mass index and chronic kidney disease: a population-based, cross-sectional study of a Japanese community. Vase. Hlth Risk Manag. 2009;5(1):315-320.
6. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am. J. Kidney Dis. 2008;52(1):39-48.
7. Kramer H., Luke A., Bldani A. et al. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am. J. Kidney Dis. 2005;46(4):587-594. (Pubitemid 41383936)
8. Munkhaugen J., Lydersen S., Widere T. E., Hallan S. Prehypertension, obesity, and risk of kidney disease: 20-year followup of the HUNT I study in Norway. Am. J. Kidney Dis. 2009;54(4):638-646.
9. Chen J., Muntner P., Hamm L. L. et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann. Intern. Med. 2004;140(3):167-174.
10. Chen J., Gu D., Chen C. S. et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol. Dial. Transplant. 2007;22(4):1100-1106. (Pubitemid 46523424)
11. Noori N., Hosseinpanah F., Nasiri A. A., Azizi F. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J. Ren. Nutr. 2009;19(3):228-237.
12. Tanaka M., Yamada S., Iwasaki Y. et al. Impact of obesity on IgA nephropathy: comparative ultrastructural study between obese and non-obese patients. Nephron. Clin. Pract. 2009;112(2):c71-c78.
13. Bonnet F., Deprele C., Sassolas A. et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am. J. Kidney Dis. 2001;37(4):720-727. (Pubitemid 32268032)
14. Lee M. N., Shaikh U., Butanl L. Effect of overweight/obesity on recovery after post-infectious glomerulonephritis. Clin. Nephrol. 2009;71(6):632-636.
15. Othman M., Kawar B., El Nahas A. M. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron. Clin. Pract. 2009;113(1):c16-c23.
16. Postorino M., Marino C., Tripepi G. et al. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J. Am. Coll. Cardiol. 2009;53(15):1265-1272.
17. Chow W. H., Devesa S. S. Contemporary epidemiology of renal cell cancer. Cancer J. 2008;14(5):288-301.
18. Klinghojfer Z, Yang B., Kapoor A., Pinthus J. H. Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert. Rev. Anticancer. Ther. 2009;9(7):975-987.
19. Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr. Nephrol. 2006;21(4):463-470.
20. Kambham N., Markowitz G. S., Valeri A. M. et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59(4):1498-1509. (Pubitemid 32281241)
21. Adelman R. D., Restaino I. G., Alon U. S., Blowey D. L. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J. Pediatr. 2001;138(4):481-485. (Pubitemid 32319719)
22. Serra A., Romero R., Lopez D. et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73(8):947-955. (Pubitemid 351458316)
23. Goumenos D. S., Kawar B., El Nahas M. et al. Early histological changes in the kidney of people with morbid obesity. Nephrol. Dial. Transplant. 2009;24(12):3732-3738.
24. Chen H. M., Li S. J., Chen H. P. et al. Obesity-related glomerulopathy in China: a case series of 90 patients. Am. J. Kidney Dis. 2008;52(1):58-65.
25. Chen H. M., Liu Z. H., Zeng C. H. et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am. J. Kidney Dis. 2006;48(5):772-779.
26. Verhave J. C., Fester P., Ribstein J. et al. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am. J. Kidney Dis. 2005;46(2):233-241. (Pubitemid 41040351)
27. Demirovic J. A., Pai A. B., Pai M. P. Estimation of creatinine clearance in morbidly obese patients. Am. J. Hlth Syst. Pharm. 2009;66(7):642-648.
28. Ritz E., Kolgeganova T., Piecha G. Is there an obesity-metabolic syndrome related glomerulopathy? Curr. Opin. Nephrol. Hypertens. 2010; In press.
29. Galic S., Oakhill J. S., Steinberg G. R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010;316(2):129-139.
30. Zhang Y., Scarpace P. J. The role of leptin in leptin resistance and obesity. Physiol. Behav. 2006;88(3):249-256.
31. Nanayakkara P. W., Le Poole C. Y., Fouque D. et al. Plasma adi-ponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3-5 chronic kidney disease. Clin. Nephrol. 2009;72(1):21-30.
32. Wolf G., Ziyadeh F. N. Leptin and renal fibrosis. Contrib. Nephrol. 2006;151:175-183. (Pubitemid 44298231)
33. Wu Y., Liu Z, Xiang Z et al. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006;147(1):44-50. (Pubitemid 43004261)
34. Sharma K., Ramachandrarao S., Qiu G. et al. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 2008;118(5):1645- 1656. (Pubitemid 351632369)
35. Ohashi K., Iwatani H, Kihara S. et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler. Thromb. Vase. Biol. 2007;27(9):1910-1917. (Pubitemid 47312299)
36. Praga M., Morales E. Obesity, proteinuria and progression of renal failure. Curr. Opin. Nephrol. Hypertens. 2006;15(5):481-486.
37. Chalmers L., Kaskel F. J., Bamgbola O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv. Chron. Kidney Dis. 2006;13(4):352-364. (Pubitemid 44512239)
38. Teplan V. Jr., VyhnSnek F., Gurlich R. et al. Increased proinflamma-tory cytokine production in adipose tissue of obese patients with chronic kidney disease. Wien. Klin. Wschr. 2010;122(15-16):466-473.
39. Ramos L. F., Shintani A., Ikizler T. A., Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J. Am. Soc. Nephrol. 2008;19(3):593-599. (Pubitemid 351355403)
40. Elmarakby A. A., Imig J. D. Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clin. Sci. (Lond.) 2010;118(4):291-301.
41. Deji N., Kume S., Araki S. et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol. Renal Physiol. 2009;296(1):F118-F126.
42. Jiang T., Wang Z., Proctor G. et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-lc-dependent pathway. J. Biol, Chem. 2005;280(37):32317-32325. (Pubitemid 41361841)
43. Bosma R. J., Krikken J. A., Homan van der Heide J. J. et al. Obesity and renal hemodynamics. Contrib. Nephrol. 2006;151:184-202. (Pubitemid 44298232)
44. Praga M., Hernandez E., Herrero J. C. et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000;58(5):2111-2118.
45. Gonzalez E., Gutierrez E., Morales E. et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int. 2005;68(1):263-270. (Pubitemid 43181384)
46. Navaneethan S. D., Yehnert H., Moustarah F. et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 2009;4(10):1565-1574.
47. Ishizaka Y., Ishizaka N., Tani M. et al. Association between changes in obesity parameters and incidence of chronic kidney disease in Japanese individuals. Kidney Blood Press. Res. 2009;32(2):141-149.
48. Shen W. W., Chen H. M., Chen H. et al. Obesity-related glomerulopa-thy: body mass index and proteinuria. Clin. J. Am. Soc. Nephrol. 2010;5(8):1401-1409.
49. Chagnac A., Weinsteint., Herman M. et al. The effects of weight loss on renal function in patients with severe obesity. J. Am. Soc. Nephrol. 2003;14(6):1480-1486. (Pubitemid 36687049)
50. Navarro-Diaz M., Serra A., Romero R. et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J. Am. Soc. Nephrol. 2006;17(12, Suppl. 3):S213-S217. (Pubitemid 44865251)
51. Serpa Neto A., Bianco Rossi F. M., Dal Moro Amarante R. et al. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J. Nephrol. 2009;22(5):637-646.
52. Huan Y., Tomaszewski J. E., Cohen D. L. Resolution of nephrotic syndrome after successful bariatric surgery in patient with biopsy-proven FSGS. Clin. Nephrol. 2009;71(1):69-73.